APTIVUS vs REYATAZ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. APTIVUS and REYATAZ are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	APTIVUS	REYATAZ
Rating	72/100	72/100
Pharmacy pays	—	~$52.63 /30
Type	RX	RX
Active ingredient	TIPRANAVIR	ATAZANAVIR SULFATE
Manufacturer	Boehringer Ingelheim	Bristol Myers Squibb
Dosage forms	Capsule	Capsule, Powder
Drug class	—	Protease Inhibitor
Boxed warning	None	None
Treats	Acquired Immunodeficiency Syndrome	Acquired Immunodeficiency Syndrome

aptivus reyataz

Rating

72/100

Pharmacy pays

—

~$52.63 /30

Type

Active ingredient

TIPRANAVIR

ATAZANAVIR SULFATE

Manufacturer

Boehringer Ingelheim

Bristol Myers Squibb

Dosage forms

Capsule

Capsule, Powder

Drug class

—

Protease Inhibitor

Boxed warning

None

Treats

Acquired Immunodeficiency Syndrome

Frequently asked questions

Which is better-rated, Aptivus or Reyataz?

Aptivus and Reyataz are tied at 3.6 out of 5 by our independent rating.

What is the difference between Aptivus and Reyataz?

Aptivus contains Tipranavir, while Reyataz contains Atazanavir Sulfate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.